Wednesday, September 30, 2015
Cancer Vaccines Make a Comeback, as Third Rock Pumps $55M into Neon Therapeutics
Cancer vaccines got a bad name years ago. First, they don’t prevent cancer—they are supposed to stimulate the immune system to fight existing tumors. Early-generation cancer vaccines that made it to clinical trials couldn't stimulate enough immune firepower to kill tumors, cost too much to manufacture, or failed for other reasons.
Awkward! How One Woman's Tinder Dates Popped Up As Professional Suggestions On LinkedIn
If you're using LinkedIn for work, and dating apps for play, and never the twain shall meet... you may need to take these precautions to keep it that way.
Egyptian Shopzilla Lands $2.7M A-Round As Country's Growth Zooms
Partners Sherif ElRakabawy and Mohamed Ewis were deep in negotiations with a venture capital firm for funding for their startup, Egyptian online shopping portal Yaoota, when suddenly: Radio silence.
What It's Like To Be A Tech Entrepreneur In Syria During The Civil War: Interview From Damascus
The story of a tech conference under fire in Syria.
Farouk Shami's Empire: On Hair, Becoming An American And Working With Donald Trump
Farouk Shami has an amazing story. A Palestinian immigrant to the United States, he founded Houston-based Farouk Systems, manufacturer of Chi and Biosilk shampoos.
Saving Jaguar: A Roman Emperor, Tyrannical Leadership and Total Quality Management
When John Egan became chief executive of Jaguar Cars chief executive in 1980, the company's survival was in grave peril. With the benefit of hindsight accorded by “Saving Jaguar,” his newly-published memoir, the situation looked “utterly hopeless”.
Subscribe to:
Posts (Atom)